Zhao Juan, Wang Jiahuan, Gu Yuanlong, Huang Xiaoyi, Wang Linyou
Daytime Treatment Center, Handan Central Hospital, Handan, Hebei 056000, P.R. China.
Biotherapy Center, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150000, P.R. China.
Oncol Lett. 2025 May 27;30(1):370. doi: 10.3892/ol.2025.15116. eCollection 2025 Jul.
Pancreatic cancer (PC) is often considered one of the most aggressive and deadly types of cancer, distinguished by its swift advancement and unfavorable prognosis. This reality highlights the vital necessity for early detection to improve patient survival rates. In recent years, notable advancements in medical technology have catalyzed the development of various diagnostic approaches, including imaging modalities, tumor markers, tissue biopsy, liquid biopsy, volatile organic compounds and nanomaterials. However, despite the promising progress in these diagnostic tools, numerous challenges persist, particularly concerning the sensitivity and specificity of these methods, as well as the complexities involved in their practical implementation in everyday clinical practice. The present review article aims to produce a thorough analysis of the applicability of each diagnostic method available for PC, highlighting their respective strengths and limitations while providing clinical recommendations aimed at enhancing the early identification of this formidable disease.
胰腺癌(PC)通常被认为是最具侵袭性和致命性的癌症类型之一,其特点是进展迅速且预后不佳。这一现实凸显了早期检测对于提高患者生存率的至关重要性。近年来,医学技术的显著进步推动了各种诊断方法的发展,包括成像方式、肿瘤标志物、组织活检、液体活检、挥发性有机化合物和纳米材料。然而,尽管这些诊断工具取得了令人鼓舞的进展,但仍存在许多挑战,特别是这些方法的敏感性和特异性,以及在日常临床实践中实际应用所涉及的复杂性。本综述文章旨在对现有的每种用于胰腺癌的诊断方法的适用性进行全面分析,突出它们各自的优势和局限性,同时提供旨在加强对这种可怕疾病早期识别的临床建议。